title: Epidemiological, clinical and therapeutic evaluation of the Italian cholera epidemic in 1994.
abstract: In the period between 18 October and 4 December 1994, 12 indigenous cases of cholera were registered in the southern Italian region of Puglia, 10 of them were diagnosed in our Departments of Infectious Diseases. All patients were infected by consumption of raw fish or mussels. The patients had an elevated mean age and most were affected with systemic pathologies. The clinical course was mild and rarely complicated, although frequently the characteristic riziform diarrhoea was absent. In all patients V. cholerae serotype Ogawa biotype El Tor, was isolated; one patient was co-infected by Salmonella typhi. All strains showed resistance to cotrimoxazole and tetracycline. Nine of ten patients were treated with oral ciprofloxacin at 1 g/day for 10 days resulting in disappearance of the symptoms within a median of 36 hours and negative fecal cultures within a median of 24 hours. Our data suggest that Italy is at high risk of infection imported from nearby nations. The resistance to commonly used antibiotics for treatment of cholera and the good response to ciprofloxacin suggest including fluoroquinolones among the drugs of first choice geographical areas involved in the circulation of resistant strains of V. cholerae O1.
authors.affiliation: Institute of Infectious Diseases, University of Bari, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Maggi
authors.forename: S
authors.initials: S
authors.lastname: Carbonara
authors.forename: C
authors.initials: C
authors.lastname: Fico
authors.forename: T
authors.initials: T
authors.lastname: Santantonio
authors.forename: C
authors.initials: C
authors.lastname: Romanelli
authors.forename: E
authors.initials: E
authors.lastname: Sforza
authors.forename: G
authors.initials: G
authors.lastname: Pastore
mesh_terms: D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002771:Cholera / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology; D002939:Ciprofloxacin / Q000627:therapeutic use; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017747:Seafood / Q000506:poisoning; D014734:Vibrio cholerae / Q000187:drug effects
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin